Blog
RSS FeedPosted by Michael Wonder on 27 Jan 2022
Moderna aims to deliver Omicron COVID-19 vaccine by September
27 January 2022 - A COVID-19 booster shot, targeted specifically at the Omicron variant, is expected to be delivered by ...
Posted by Michael Wonder on 27 Jan 2022
Shortage of prescription infant formula worries parents
28 January 2022 - A shortage of prescription infant formula has parents worried about how they will feed their babies. ...
Posted by Michael Wonder on 24 Jan 2022
Novavax COVID-19 vaccine to be available in coming weeks
24 January 2022 - Australians aged 18+ will now have access to a fourth COVID-19 vaccine, Nuvaxovid (Novavax) in coming weeks, ...
Posted by Michael Wonder on 23 Jan 2022
Pharmacists struggle to meet demand for free COVID test kits amid stock shortage
23 January 2022 - Chemists across the country say they do not have enough rapid antigen tests to start handing ...
Posted by Michael Wonder on 22 Dec 2021
Extension to image based prescription special arrangement
22 December 2021 - The Department of Health has extended the ‘image based prescription’ interim measure which allows the supply of ...
Posted by Michael Wonder on 14 Dec 2021
mRNA manufacturing facility will deliver long term health benefits for Australians
14 December 2021 - Medicines Australia welcomes the announcement that Australia will manufacture mRNA vaccines in a deal struck with ...
Posted by Michael Wonder on 13 Dec 2021
Moderna vaccine deal to produce 100 million doses in Melbourne reached by Federal and Victorian Governments
13 December 2021 - Australia is poised to become the largest producer of mRNA vaccines outside the US and Europe ...
Posted by Michael Wonder on 13 Dec 2021
ACCC helps to protect Australians against medicine shortages caused by COVID-19
10 December 2021 - Medicine shortages from the COVID-19 pandemic will continue to be actively managed by Medicines Australia and ...
Posted by Michael Wonder on 06 Dec 2021
PHARMAC negotiates deal with Pfizer for its promising new oral antiviral treatment for COVID-19
6 December 2021 - PHARMAC has negotiated an agreement with Pfizer for its promising new oral anti-viral treatment to treat ...
Posted by Michael Wonder on 22 Nov 2021
Pfizer to provide U.S. Government with 10 million treatments courses of investigational oral antiviral candidate to help combat COVID-19
18 November 2021 - If approved or authorised, Paxlovid (PF-07321332; ritonavir) would be the first oral anti-viral of its kind, a ...
Posted by Michael Wonder on 11 Nov 2021
Valneva receives EU deal for COVID jab, and seeks apology from UK
11 November 2021 - French vaccine manufacturer, Valneva, has announced that it has won EU approval to supply up to 60 ...
Posted by Michael Wonder on 10 Nov 2021
Merck and Ridgeback announce Japanese Government to purchase 1.6 million courses of molnupiravir, an investigational oral COVID-19 anti-viral medicine, upon authorisation or approval
10 November 2021 - Merck and Ridgeback Biotherapeutics today announced that the Japanese government will purchase, upon authorization or approval, approximately ...
Posted by Michael Wonder on 09 Nov 2021
WHO warns of massive syringe shortfall in 2022
10 November 2021 - There could be a shortage of up to two billion syringes in 2022 with billions more than ...
Posted by Michael Wonder on 09 Nov 2021
Merck and Ridgeback announce U.S. Government to purchase 1.4 million additional courses of molnupiravir, an investigational oral anti-viral medicine, for the treatment of mild to moderate COVID-19 in at risk adults
9 November 2021 - Merck and Ridgeback Biotherapeutics today announced that the United States Government will exercise two of its options ...
Posted by Michael Wonder on 07 Nov 2021
COVID-19: PHARMAC confident with growing stock of drugs to treat virus
7 November 2021 - PHARMAC is growing increasingly confident it is getting close to having enough of the drugs needed to ...